Automated Lab Platform for Life Sciences
Transforming healthcare, biopharma, and R&D
Who we are

Biology holds the solution to humanity’s grand challenges

At present, the development of those solutions is hindered by slow, expensive, and overly complex lab workflows.

We are dedicated to developing a platform that integrates robotics, software, assay development, and lab operations to supercharge the pace of innovation in life sciences.

What we do

We supply sequencing services to healthcare systems and governments, offering affordable, high-throughput sequencing solutions.

We offer genome-scale cell engineering solutions for biopharma, enabling the development of novel therapeutics.

We create flexible, easy-to-use robotics to help life science labs in academia and industry automate their operations.

Our business
Opentrons Robotics
Opentrons Robotics
Opentrons Robotics is the industry leader in flexible, user-friendly lab automation. Opentrons Robotics' flagship product, the OT-2, can be found in thousands of labs in more than 40 countries.
Neochromosome
Neochromosome
Neochromosome uses the Opentrons platform to create genome-scale cell engineering solutions for therapeutics.
Zenith AI
Zenith AI
Zenith AI brings proprietary no-code AI and modern machine learning to the Opentrons platform.
Our leadership
Executive team
  • Photo of Jon Brennan-Badal
    Jon Brennan-Badal
    CEO, Opentrons Labworks, Inc.
  • Photo of Gautam Prabhu
    Gautam Prabhu
    CTO, Opentrons Labworks, Inc
Board and Advisors
  • Photo of Myrtle Potter
    Myrtle Potter
    Chair of the Board, Opentrons Labworks, Inc
  • Photo of Robert S. Langer
    Robert S. Langer
    Head of Scientific Advisory Board, Neochromosome, Inc
  • Photo of Vinod Khosla
    Vinod Khosla
    Member of the Board, Opentrons Labworks, Inc
  • Photo of Alex Morgan
    Alex Morgan
    Member of the Board, Opentrons Labworks, Inc
  • Photo of Angela Du
    Angela Du
    Member of the Board, Opentrons Labworks, Inc
  • Photo of Eric Hippeau
    Eric Hippeau
    Member of the Board, Opentrons Labworks, Inc
  • Photo of Sven Strohband
    Sven Strohband
    Member of the Board, Opentrons Labworks, Inc
48
Countries
6,000+
Happy Customers
$250M+
Funds Raised
250
Team Members
Our Investors
  • investor logo
  • investor logo
  • investor logo
  • investor logo
  • investor logo
  • investor logo
Opentrons announces $200 million series C led by Softbank
Opentrons will use this funding to scale its automated lab platform for life sciences and healthcare.
Read more →
https://www.cigna.com/legal/compliance/machine-readable-files

This link leads to the machine-readable files that are made available in response to the federal Transparency in Coverage Rule and includes negotiated service rates and out-of-network allowed amounts between health plans and healthcare providers. The machine readable files are formatted to allow researchers, regulators, and application developers to more easily access and analyze data.

facebook
instagram
twitter
youtube
© 2023 Opentrons Labworks